Article
[The INCA trial (impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver cirrhosis and ascites): precision medicine for patients with liver cirrhosis and ascites].
Zeitschrift fur Gastroenterologie - 1 Nov 2015
Casper M, Appenrodt B, Grünhage F, Lammert F
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.